| Modeling, molecular dynamics simulation, and mutation validation for structure of cannabinoid receptor 2 based on known crystal structures of GPCRs Z Feng, MH Alqarni, P Yang, Q Tong, A Chowdhury, L Wang, XQ Xie Journal of chemical information and modeling 54 (9), 2483-2499, 2014 | 108 | 2014 |
| Supramolecular Assembly of Toll-like Receptor 7/8 Agonist into Multimeric Water-Soluble Constructs Enables Superior Immune Stimulation In Vitro and In Vivo TRF Alexander K. Andrianov*, Alexander Marin, Ruixue Wang, Hatice Karauzum ... ACS Applied Bio Materials 3 (5), 3187-3195, 2020 | 30 | 2020 |
| Tissue Inhibitor of Metalloprotease-2 (TIMP-2): bioprocess development, physicochemical, biochemical and biological characterization of highly expressed recombinant protein. SSWG Chowdhury A, Brinson RG, Wei B Biochemistry, 2017 | 26 | 2017 |
| Mistic and TarCF as fusion protein partners for functional expression of the cannabinoid receptor 2 in Escherichia coli A Chowdhury, R Feng, Q Tong, Y Zhang, XQ Xie Protein expression and purification 83 (2), 128-134, 2012 | 22 | 2012 |
| In Vivo and In Vitro Potency of Polyphosphazene Immunoadjuvants with Hepatitis C Virus Antigen and the Role of Their Supramolecular Assembly TRF Alexander K. Andrianov*, Alexander Marin, Ruixue Wang, Ananda Chowdhury ... Molecular Pharmaceutics, 2020 | 18 | 2020 |
| Copper-binding anticancer peptides from the piscidin family: an expanded mechanism that encompasses physical and chemical bilayer disruption F Comert, F Heinrich, A Chowdhury, M Schoeneck, C Darling, ... Scientific reports 11 (1), 12620, 2021 | 14 | 2021 |
| Next generation polyphosphazene immunoadjuvant: Synthesis, self-assembly and in vivo potency with human papillomavirus VLPs-based vaccine A Marin, A Chowdhury, SM Valencia, A Zacharia, R Kirnbauer, ... Nanomedicine: Nanotechnology, Biology and Medicine 33, 102359, 2021 | 13 | 2021 |
| Advances in methods to characterize ligand-induced ionic lock and rotamer toggle molecular switch in G protein-coupled receptors XQ Xie, A Chowdhury Methods in enzymology 520, 153-174, 2013 | 11 | 2013 |
| Macromolecule-network electrostatics controlling delivery of the biotherapeutic cell modulator TIMP-2 Y Yamada, A Chowdhury, JP Schneider, WG Stetler-Stevenson Biomacromolecules 19 (4), 1285-1293, 2018 | 9 | 2018 |
| Nano-assembly of quisinostat and biodegradable macromolecular carrier results in supramolecular complexes with slow-release capabilities A Chowdhury, A Marin, DJ Weber, AK Andrianov Pharmaceutics 13 (11), 1834, 2021 | 3 | 2021 |
| TIMP‐2 Inhibits Triple Negative Breast Cancer Growth and Metastasis through EMT Suppression and Promotion of Vascular Normalization SM Jensen, S Kumar, A Chowdhury, N Castro, J Shih, DS Salomon, ... The FASEB Journal 32, 678.2-678.2, 2018 | 3 | 2018 |
| Preclinical development of recombinant human tissue inhibitor of metalloprotease‐2 as a novel biologic therapy for cancer A Chowdhury, B Wei, S Noonan, W Stetler‐Stevenson The FASEB Journal 29, 945.16, 2015 | 3 | 2015 |
| Metallated Anticancer Peptides: An Expanded Mechanism that Encompasses Physical and Chemical Bilayer Disruption F Comert, F Heinrich, A Chowdhury, M Schoeneck, C Darling, ... FASEB J 36, 2022 | 1 | 2022 |
| Recombinant human Tissue Inhibitor of Metalloprotease− 2; a novel anti‐cancer therapeutic A Chowdhury, B Wei, Y Yamada, N Castro, D Salomon, JP Schneider, ... The FASEB Journal 31, 823.10-823.10, 2017 | 1 | 2017 |
| TIMP‐2: A Novel Biologic Therapy for Triple Negative Breast Cancer NP Castro, A Chowdhury, SM Jensen, F Cuttitta, WG Stetler‐Stevenson, ... The FASEB Journal 30, 698.2-698.2, 2016 | 1 | 2016 |
| TIMP‐2 Deficiency Alters Host Immune Response in Murine Lung Tumor Microenvironment SM Jensen, S Kumar, A Chowdhury, B Wei, WG Stetler‐Stevenson The FASEB Journal 30, 697.7-697.7, 2016 | 1 | 2016 |
| Copper‑binding anticancer peptides fromthepiscidin family: anexpanded mechanism thatencompasses physical andchemical bilayer disruption F Comert, F Heinrich, A Chowdhury, M Schoeneck, C Darling, K Anderson, ... Fatih Comert, Frank Heinrich, Ananda Chowdhury, Mason Schoeneck, Caitlin …, 2021 | | 2021 |
| TIMP‐2 Inhibits Tumor Growth in Murine Model of Lung Cancer through EGFR signaling S Kumar, SM Jensen, A Chowdhury, D Peeney, B Wei, J Shih, JJ Caterina, ... The FASEB Journal 32, 281.9-281.9, 2018 | | 2018 |
| Development of Inert, Injectable Sustained Release Formulation for Recombinant Human TIMP‐2 in peptide hydrogels A Chowdhury, Y Yamada, JP Schneider, WG Stetler‐Stevenson The FASEB Journal 32, 830.8-830.8, 2018 | | 2018 |
| Loss of function mutation in TIMP2 gene accelerates tumorigenesis and mortality in murine model of lung cancer through EGFR signaling S Kumar, S Jensen, D Peeney, A Chowdhury, B Wei, ... The FASEB Journal 31, 656.5-656.5, 2017 | | 2017 |
